Skip to main content
Premium Trial:

Request an Annual Quote

DiagnoCure's Q1 Revenues Jump 90 Percent

NEW YORK (GenomeWeb News) – DiagnoCure today reported a 90 percent increase year over year in revenues for its fiscal first quarter of 2012.

For the period ended Jan. 31, revenues totaled C$556,158, (US$557,400) compared to C$292,878 a year ago. During the quarter, the Quebec City-based firm received C$268,567 from Signal Genetics for R&D services provided related to the Previstage GCC Colorectal Cancer Staging Test.

The firms inked deals in June granting Signal the rights to commercialize DiagnoCure's test and acquire its CLIA service laboratory. They also plan to develop additional genomic cancer tests.

DiagnoCure said that its royalty revenues in the first quarter increased to C$163,791 from C$161,790 a year ago.

The firm's R&D costs, net of investment tax credits rose to C$802,228, a 25 percent increase from C$643,711 a year ago, due primarily to services provided in support of the Previstage colorectal cancer test, DiagnoCure said. Its SG&A costs were reduced 14 percent to C$599,475 from C$696,066 a year ago.

The firm had a net loss of C$816,164, or C$.02 per share, compared to a net loss of C$1.4 million, or C$.03 per share, a year ago.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.